Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (571-580 of 894) with videos related to

Pageof 90
Sort By:
Acta Diabetologica|October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trialFabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.
Nephron|November 5, 2023
Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative GlomerulonephritisGiulia Villa, Erica Daina, Paolo Brambilla, et al.
Kidney International|August 8, 2002
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1Carla Zoja, Stefania Angioletti, Roberta Donadelli, et al.
JCI Insight|March 13, 2020
C3a receptor blockade protects podocytes from injury in diabetic nephropathyMarina Morigi, Luca Perico, Daniela Corna, et al.
JCI Insight|September 20, 2019
Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytesValentina Benedetti, Angelo Michele Lavecchia, Monica Locatelli, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulationElisabetta Valoti, Marta Alberti, Agustin Tortajada, et al.
Nature Reviews. Nephrology|September 20, 2025
Two decades of nephrology research: progress and future challengesUrmila Anandh, Hans-Joachim Anders, Justine Bacchetta, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trialAneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.
Frontiers in Immunology|July 19, 2021
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration PlasmapheresisDiego Curtò, Federica Tomatis, Sara Gastoldi, et al.
Pageof 90

Showing results (571-580 of 894) with videos related to

Sort By:
Pageof 90
Acta Diabetologica|October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trialFabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.
Nephron|November 5, 2023
Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative GlomerulonephritisGiulia Villa, Erica Daina, Paolo Brambilla, et al.
Kidney International|August 8, 2002
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1Carla Zoja, Stefania Angioletti, Roberta Donadelli, et al.
JCI Insight|March 13, 2020
C3a receptor blockade protects podocytes from injury in diabetic nephropathyMarina Morigi, Luca Perico, Daniela Corna, et al.
JCI Insight|September 20, 2019
Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytesValentina Benedetti, Angelo Michele Lavecchia, Monica Locatelli, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulationElisabetta Valoti, Marta Alberti, Agustin Tortajada, et al.
Nature Reviews. Nephrology|September 20, 2025
Two decades of nephrology research: progress and future challengesUrmila Anandh, Hans-Joachim Anders, Justine Bacchetta, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trialAneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.
Frontiers in Immunology|July 19, 2021
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration PlasmapheresisDiego Curtò, Federica Tomatis, Sara Gastoldi, et al.
Pageof 90